(NASDAQ: REGN) and Sanofi today presented results from the DISCOVER Phase 4, single-arm, open-label trial assessing Dupixent ® (dupilumab) in adults and adolescents with moderate-to-severe atopic ...

Hypertension kills more people than any other condition. In the U.S., despite spending more than $4 trillion a year on ...

Women, people from ethnic minority backgrounds, and those from the most deprived communities are less likely to receive ...

Psychotherapy aids by either confronting issues or helping clients adjust to them. It improves well-being, whether through ...

Psychedelics research gains support from the Trump administration for treating PTSD and mental health conditions, with Veterans Affairs exploring treatments that show promise in clinical trials.

Alzheimer's disease, marked by memory loss, trouble concentrating and thinking, and changes in personality and behavior, ...

Insomnia affects millions and is closely linked to heart and mental health. Here's what we know about causes, treatments, and ...

The HHS secretary said people should have access to experimental therapies including unregulated uses of stem cells. But some ...

Voyager struggles with a negative enterprise value, financial risks, and limited catalysts in a competitive Alzheimer's ...

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

CURE spoke with the principal investigator of a clinical trial evaluating a therapeutic vaccine for patients with advanced ...

New research presented at the 2025 American Society for Clinical Oncology’s (ASCO) annual meeting has shed light on the ...